Animal Growth Promoters and Performance Enhancers Market - Global Forecast to 2024

The growth of this market is primarily driven by the increasing global meat demand, research into alternatives to antibiotics, and the need to deal with epidemics and environmental factors. However, various countries have stringent regulations in place against antibiotics and particular growth promoters, which has affected their adoption.

The report Animal Growth Promoters and Performance Enhancers Market is projected to reach USD 18.5 billion by 2024 from an estimated USD 13.9 billion in 2019, at a CAGR of 5.9% during the forecast period.

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137134167

Based on type, the animal growth promoters and performance enhancers market is segmented into antibiotic and non-antibiotic growth promoters. The non-antibiotic growth promoters segment accounted for the largest share of the animal growth promoters and performance enhancers market in 2018. The large share of this segment can be attributed to their economic benefits, the wide range of substances with applications in different production animals, environmental sustainability, and the increasing number of regulations on antibiotics and hormones.

On the basis of animal type, the animal growth promoters and performance enhancers market is segmented into poultry, swine, livestock, aquaculture, and other farm animals (equine, rabbit, camel, deer, yak, and geese). In 2019, the poultry segment accounted for the largest share of the animal growth promoters and performance enhancers market. 

In 2019, the Asia Pacific region accounted for the largest market share of 36.7%, followed by North America (26.1%) in 2018. The largest share of the Asia Pacific region is attributed to the strong animal products industry in this region, 

Read more: - https://www.marketsandmarkets.com/PressReleases/animal-growth-promoters-performance-enhancers.asp

The key players in the global animal growth promoters and performance enhancers market are Merck and Co. Inc. (US), Cargill Inc. (US), Royal DSM N.V. (Germany), Vetoquinol (France), Bupo Animal Health (SA), Elanco Animal Health Inc. (US), CHR Hansen (UK), Novus International Inc. (US),  BASF SE (UK), Lallemond Inc. (Canada), Bluestar Adisseo Company (France), Evonik Industries AG (UK), and Land O Lake Inc.(US).

Animal Wound Care Market to witness major growth in coming years

The growth in this market is majorly attributed to factors such as rising pet adoption, increasing number of veterinary practitioners and rise in their income levels in developed economies, rising demand for pet insurance coupled with growing animal health expenditure, and rising awareness about animal health.

The Animal Wound Care Market witnessed healthy growth during the last decade and is expected to grow at a CAGR of 6.7% between 2016 and 2021 to reach 1,134.0 Million by 2021. 

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253831778

The global animal wound care market is segmented based on product, animal type, end user, and geography. 

Based on product type, the market is segmented into surgical wound care products, advanced wound care products, traditional wound care products, and therapy devices. Based on animal type, the market is segmented into companion animals and livestock animals. On the basis of end-users, the global animal wound care market is segmented into hospitals & clinics and home care. Similarly, on the basis of geography, the animal wound care market is segmented into North-America, Europe, Asia-Pacific, and Rest of the World.

In 2015, surgical wound care product segment accounted for the largest share of the global animal wound care.  The large share is mainly attributed to greater adoption of these products in hospitals and clinics for wound healing, rising incidence of wounds in pets, and increasing number of surgeries.  However, advanced wound care products segment is expected to witness the highest growth over the next five years.

The companion animals segment accounted for the largest share of the animal wound care market and is expected to grow at a highest CAGR in the forecasted period. The large share and high growth of this segment can mainly be attributed to the growing companion animal population, increasing pet care expenditure, and growing demand for pet insurance across the globe.

North America is the largest regional segment for animal wound care owing to the well-established animal healthcare market. The largest share of this regional segment is driven by growing pet adoption, increasing number of veterinary conditions requiring surgeries, rising animal healthcare expenditure, and growing number of veterinary practitioners and their income levels. 

Read More: - https://www.marketsandmarkets.com/PressReleases/animal-wound-care.asp

The market players, namely, B Braun Melsungen AG (Germany), Medtronic plc (Ireland), 3M Company (U.S.), and Ethicon Inc. (U.S.) held the major share of the animal wound care market.

Chromatography Instruments Market statistics and research analysis released in latest report

The rising popularity of hyphenated chromatography techniques, the growing importance of chromatography tests in the drug approval process, and rising food safety concerns are the major factors driving the growth of this market.

The report Chromatography Instruments Market was valued at USD 7.8 billion in 2017. This market is estimated to grow at a CAGR of 6.9% during the forecast period, expected to be worth USD 10.9 billion by 2022.

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1258

Based on type, the chromatography instruments market is segmented into systems, detectors, auto-samplers, and fraction collectors. The systems segment dominated this market in 2017 and is also estimated to grow at the highest CAGR during the forecast period. Technological advancements and the improved capabilities of chromatography systems to analyze complex compounds are the major factors driving the growth of this segment.

North America was the largest revenue generator of the global chromatography instruments market in 2017, closely followed by Europe. Increasing funding for R&D activities in the life science industry in the US is one of the major factors responsible for the large share of North America in the chromatography instruments market. 

Life science research, food & beverage testing, environmental testing, and other applications are the main segments of the market. Life science research is the largest and the fastest-growing application segment in this market majorly due to the increasing importance of chromatography tests in the drug approval process and the rising number of R&D activities in the pharmaceutical and biotechnology industries.

In the coming years, the growth of the European market would be driven by factors such as the increasing focus on food safety in the UK, growth of the cosmetics industry in France, and the rising pharmaceutical R&D expenditure in RoE (Rest of Europe) countries.

Read More: - https://www.marketsandmarkets.com/PressReleases/chromatography-instrumentation.asp

The key players present in this market include Agilent Technologies, Inc. (US), Waters Corporation (US), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (US), and PerkinElmer, Inc. (US).

New report examines the mHealth Solutions Market

The growing adoption of smartphones, increasing penetration of 3G/4G networks, rising focus on cost containment in healthcare delivery, and the increasing demand for home healthcare services are some of the key factors driving the growth of this market.

The report mHealth Solutions Market is projected to reach USD 213.6 billion by 2025 from USD 50.8 billion in 2020, at a CAGR of 33.3 % during the forecast period. 

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1232

Based on product and service, the mHealth apps segment accounted for the largest share of the mHealth solutions market in 2019. The large share of this segment can be attributed to the high and growing penetration of smartphones and healthcare apps and the rising incidence of chronic and lifestyle-related diseases across the globe (coupled with the effective utilization of apps in chronic disease management).

Based on region, the mHealth solutions market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest market share in 2019. 

This is due to the increasing penetration of smartphones, rising prevalence of chronic and lifestyle disorders, increasing healthcare costs, increasing demand for better healthcare services, government initiatives to promote digital health, robust penetration of 3G and 4G networks, and the rising awareness of self-health management.

Read More: - https://www.marketsandmarkets.com/PressReleases/mhealth-apps-and-solutions.asp

The prominent players in this market are Medtronic plc (Ireland), Apple, Inc. (US), AirStrip Technologies (US), AliveCor, Inc. (US), Nike, Inc. (US), Koninklijke Philips N.V. (Netherlands), Johnson & Johnson (US), Omron Corporation (Japan), BioTelemetry, Inc. (US), athenahealth, Inc. (US), AgaMatrix, Inc. (US), Withings S.A. (France), and iHealth Labs, Inc. (US).

Patient Registry Software Market Set for Rapid Growth and Trend by 2022

The growth of the market is attributed to the growing implementation of government initiatives to build patient registries, rising pressure to improve the quality of care and reduce healthcare costs, rising adoption of EHRs, and growing use of patient registry data for post-marketing surveillance. The rising number of accountable care organizations, emergence of cloud-based patient registry solutions & high adoption rate of subscription models, and shifting focus towards patient-powered research networks (PPRNS) are expected to offer significant growth opportunities for players in the coming years.

The global Patient Registry Software Market is expected to reach USD 1,429.1 Million by 2022 from USD 807.4 Million in 2017, at a CAGR of 12.1%.

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144694594

Based on type of registry, the market is segmented into product registries (medical device and drug registries), health service registries, and disease registries (diabetes registries, cardiovascular registries, cancer registries, rare disease registries, asthma registries, chronic kidney disease registries, orthopedic registries, and other registries). The disease registries segment is expected to dominate the market in 2017. The growth of this segment can be attributed to the factors such as increasing aging population, rising prevalence of chronic and rare & new diseases, growing awareness on the role of registries in health management, and increasing adoption of EHRs across the globe.

Based on end user, the market is segmented into government organizations & TPAs (third-party administrators); hospitals and medical practices; private payers; pharmaceutical, biotechnology, and medical device companies; and research centers. The hospitals and medical practices segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors like increasing focus on improving the quality of patient care, growing adoption of EHRs, and implementation of pay-for-performance initiatives.

In 2017, North America is expected to account for the largest share of the market. Growth in the North American market can largely be attributed to the presence of major patient registry software developing players and the high adoption rate of these solutions in the region. Other drivers include the increasing need to integrate healthcare systems, government funding for developing patient registries, rising focus on population health management & health information exchange, increasing adoption of HCIT as a cost-containment measure, and increasing participation of non-profit and private organizations in improving patient care quality.

Read more: - https://www.marketsandmarkets.com/PressReleases/patient-registry-software.asp

Key players in this market include Phytel, Inc. (US), QUINTILES IMS HOLDINGS, INC. (US), Liaison Technologies. (US), ImageTrend, Inc. (US), FIGmd, Inc. (US), McKesson Corporation (US), CECity.com Inc. (a Premier, Inc. Company) (US), Dacima Software Inc. (US), Global Vision Technologies, Inc. (US), ifa systems AG, (Germany), INC RESEARCH HOLDINGS, INC. (US), M2S (A Medstreaming Company) (US), Optum, Inc (A part of UnitedHealth Group Incorporated) (US), EVADO Pty. Ltd. (Australia), and Velos, Inc. (US).

Research details developments in the Blood Screening Market worth $3.5 billion by 2025

The increasing demand for donated blood, the rising number of blood donations, the growing prevalence of infectious diseases, and the increasing prevalence of newer pathogens are the key factors driving the growth of this market.

The Blood Screening Market is projected to reach USD 3.5 billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 12.8%.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042

Based on product & service, the blood screening market is segmented into reagents and kits, instruments, and software and services. The reagents and kits segment accounted for the largest share of the blood screening market in 2019. The large share of this segment can be attributed to the high consumption and repeated use of reagents & kits in blood screening procedures. Also, the accessibility of a wide range of reagents and the need for reliable, specific, and fast detection of TTIs are driving the growth of the blood screening reagents & kits market.

Based on end users, the blood screening market is segmented into blood banks and hospitals. The blood bank segment accounted for the larger market share in 2019 and is projected to witness a higher growth rate during the forecast period. This can be attributed to the increasing demand for donated blood, a growing number of organ transplantation surgeries, rising awareness regarding the safety of blood, an increasing number of donations worldwide, and growth in government funding to charitable trusts.

Based on region, the blood screening market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. In 2019, North America accounted for the largest market share, followed by Europe.

Read More: - https://www.marketsandmarkets.com/PressReleases/blood-screening.asp

The prominent players operating in the blood screening market include Grifols (Spain), F. Hoffmann-La Roche AG (Switzerland), Abbott Laboratories (US), BioMérieux (France), Bio-Rad Laboratories (US), Siemens Healthineers (Germany), Danaher Corporation (US), Thermo Fisher Scientific Inc. (US) ,Ortho Clinical Diagnostics, Inc.(US), Becton, Dickinson and Company (US), DiaSorin (Italy), GFE (Germany), Trinity Biotech (Ireland), Merck Millipore (Germany), GE Healthcare (US), Perkin Elmer (US), Bio-Techne Corporation (US), and J Mitra & Co. Pvt. Ltd (India).

New report examines the High-performance Liquid Chromatography (HPLC) Market worth $5.7billion by 2025

The growth in this market is driven by high sensitivity &accuracy of the HPLC technique, the growing importance of HPLC tests in drug approvals,the rising popularity of hyphenated techniques, and increasing pharmaceutical R&D spending. However, the high cost of HPLC systems is expected to restrict market growth to a certain extent.

The report High-performance Liquid Chromatography (HPLC) Market , is projected to reach USD 5.7billion by 2025 from USD 4.5billion in 2020, at a CAGR of 4.6% during the forecast period. 

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=117899209

Based on the product, the market was divided into instruments, consumables, and accessories. The instrument market is subjected to account for the largest share in the HPLC market and consumables to growth at the highest rate during the forecast period. The need to analyze compounds in trace concentration and the extensive use of the system in forensic institutes and industries such as pharmaceuticals, food, nutraceuticals, cosmetics, and environmental testing calls for growth of the segment.

Based on the application, the HPLC market is divided into clinical research, diagnostics, forensics, and other applications. Clinical research is subjected to grow at the highest rate in the forecast period. A rise in pharmaceutical and biotechnological research fueled by the need for numerous preclinical and clinical studies performed during the drug discovery and development processis said to drive the market.

North America is expected to account for the largest share of the global HPLC market. Market growth in this region is driven primarily by the increase in R&D funding, the growing number of preclinical activities by CROs &pharmaceutical companies, and the increasing food & agricultural industry in Canada. 

Read More: - https://www.marketsandmarkets.com/PressReleases/hplc.asp

The global HPLC market is well established owing to the dominance of prominent market players, such as Waters (US), Agilent (US), Shimadzu (Japan), Thermo Fisher (US), PerkinElmer (US), GE Healthcare (US), Bio-Rad (US), Merck Millipore (Germany), Hitachi (Japan), Showa Denko (Japan), Gilson (US), Phenomenex (US), JASCO (US), Hamilton Company (US), SIELC (US), Orochem (US), YMC Co. Ltd. (Japan), Restek (US), Trajan Scientific (Australia), and Tosoh Bioscience LLC (Japan).

Stem Cell Therapy Market to witness major growth in coming years

Factors such as the growing awareness related to the therapeutic potency of stem cells in disease management, development of advanced genome-based cell analysis techniques, increasing public-private investments for stem cell research, identification of new stem cell lines, and developments in infrastructure for stem cell banking and processing are propelling the growth of the global stem cell therapy market.

The report studies the Stem Cell Therapy Market during the forecast period of 2016 to 2022. The market is expected to reach USD 161.8 million by 2022, growing at a CAGR of 11.0% during the forecast period. 

Download PDF Brochure:- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=48

On the basis of mode of therapy, the global stem cell therapy market is divided into two major categories, namely, allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic stem cell therapy segment is expected to command the largest share of 95.2% in the global stem cell therapy market in 2017 growing at a CAGR of 11.2% during the forecast period. 

On the basis of therapeutic application, the global stem cell therapy market is segmented into musculoskeletal disorders, wounds and injuries, cardiovascular diseases, surgeries, gastrointestinal diseases, and other applications. The musculoskeletal disorders segment is expected to command the largest share of 61.1% in the global stem cell therapy market in 2017. Furthermore, the CVS diseases segment is expected to grow at the highest CAGR of 13.0% during the forecast period. 

On the basis of cell source, the global stem cell therapy market is divided into adipose derived MSCs, bone marrow derived MSCs, embryonic / cord blood SCs, and other cell sources. The adipose derived MSCs segment was expected to account for the largest share of 59.1% in the global stem cell therapy market in 2017. Furthermore, the bone marrow derived MSCs segment is expected to grow at highest CAGR of 12.1% during the forecast period.

North America is expected to be the largest regional segment in the global stem cell therapy market in 2017, followed by Asia-Pacific. In addition, the North American stem cell therapy market is expected to be the fastest growing region during the forecast period, growing at a CAGR of 11.5%. 

Read More: - https://www.marketsandmarkets.com/PressReleases/stem-cells-market.asp

As of 2016, Osiris Therapeutics, Inc. (U.S.), MEDIPOST Co., Ltd. (South Korea), Anterogen Co., Ltd. (South Korea), Pharmicell Co., Ltd. (South Korea), Holostem Terapie Avanzate S.r.l. (Italy), JCR Pharmaceuticals Co., Ltd. (Japan), NuVasive, Inc. (U.S.), RTI Surgical, Inc. (U.S.), and AlloSource (U.S.) were some of the key players operating in the global stem cell therapy market.

Pharmaceutical Packaging Equipment Market - Emerging Trends and Global Future Forecast

The major factors driving the growth of this market largely driven by the growth in the generic and biopharmaceutical markets, the growing need for flexible and integrated packaging equipment, the increase in offshore pharmaceutical manufacturing, growing contract manufacturing of pharmaceutical products, and the introduction of regulatory standards on packaging & stringent norms against counterfeit products. Moreover, the pharmaceutical industry is witnessing a shift toward the use of biopharmaceuticals and biological drugs. This has led to an increased demand for innovative packages.

The Pharmaceutical Packaging Equipment Market is expected to reach USD 8.9 billion by 2023 from an estimated USD 6.2 billion in 2018, at a CAGR of 7.4%. 

Download PDF Brochure :-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828

Based on product, the market is divided into primary packaging equipment, secondary packaging equipment, and labeling and serialization equipment. The primary packaging equipment segment accounted for the largest share in the pharmacetuical packaging equipment market. The ease of handling and shelving of pharmaceuticals after primary packaging, development of novel forms of drug delivery and biopharmaceuticals (stimulating the need for innovation in primary packaging), and the increasing number of regulatory norms and quality control criteria have contributed to the largest share of primary packaging equipment in pharmaceutical packaging equipment market.

Based on type, the pharmaceutical packaging equipment market is segmented into liquid, solid, semi-solid, and other packaging equipment. The liquid packaging equipment segment is expected to account for the largest share of the global pharmaceutical packaging equipment market during the forecast period of 2018 to 2023.

The large share of this segment can be attributed to the transition toward new biopharmaceutical compounds (leading to the production of increasingly complex formulations), rising incidence of eye disorders, and development of novel drug delivery systems have increased the demand for novel packaging, such as automated and integrated packaging lines.

Europe is expected to account for the largest share of the pharmaceutical packaging equipment market in 2018, followed by North America and the Asia Pacific.

Read More: - https://www.marketsandmarkets.com/PressReleases/pharmaceutical-packaging-equipment.asp

The prominent players in the pharmaceutical packaging equipment market are Robert Bosch (Germany), IMA (Italy), Marchesini Group (Italy), Körber (Germany), MG2 (Italy), Uhlmann Group (Germany), Accutek Packaging Equipment Companies (US), Vanguard Pharmaceuticals Machinery (US), Romaco Holding (Germany), Bausch + Ströbel (Germany), OPTIMA Packaging Group (Germany), ACG Worldwide (India), Coesia (Italy), and MULTIVAC Group (Germany).

Report explores the Healthcare EDI Market worth $3.77 Billion by 2022

The rising adoption of EDI services by hospitals in supply chain management and government efforts to improve healthcare coverage & streamline healthcare delivery & reimbursement processes are majorly contributing to the growth of the European healthcare EDI market, which holds the second-largest market share

The Healthcare EDI Market is expected to reach USD 3.77 Billion by 2022 from an estimated USD 2.56 Billion in 2017, at a CAGR of 8.1%. The growth of the market is mainly driven by the rising need to curtail healthcare costs, mandatory regulations for transaction processes, and government support for HCIT.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130571438

On the basis of component, the services segment accounted for the largest share of the global healthcare EDI market. This is primarily attributed to the increasing complexity and scale of EDI solutions, as they require extensive training programs, and rise in outsourcing activities. The services segment is also expected to grow at the highest CAGR during the forecast period.

Based on delivery mode, the web & cloud-based EDI segment accounted for the largest share of this market. The low cost of web and cloud-based EDI, non-requirement of software installations, compatibility with mobile devices, and high scalability are the major factors driving the use of web & cloud-based EDI, which has boosted the demand for effective EDI implementation.

North America accounted for the largest share of the healthcare EDI market in 2016, followed by Europe and Asia-Pacific..

Read More: - https://www.marketsandmarkets.com/PressReleases/healthcare-edi.asp

The prominent players in the global healthcare EDI market are McKesson Corporation (U.S.), GE Healthcare (U.S.), Allscripts Healthcare Solutions Inc. (U.S.), Cognizant Technology Corporation (U.S.), SSI Group, LLC (U.S.), Cerner Corporation (U.S.), Comarch SA (Poland), Axway Software SA (France), Optum Inc. (U.S.), Dell Technologies Inc. (U.S.), Quality Systems Inc. (U.S.), and Synnex Corporation (U.S.).

Report explores the Research Antibodies Market is expected to reach $ 12.60 Billion by 2022

Factors such as the increasing R&D activities and expenditure in the life science industry, increasing funding for proteomics research and drug discovery, and the growing collaboration between industries and academic institutes are the key drivers of the research antibodies market.

The Research Antibodies Market is expected to reach USD 12.60 Billion by 2022 from an estimated USD 9.33 Billion in 2017, at a CAGR of 6.2% during the forecast period. 

Download PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793

Based on technology, the western blotting segment accounted for the largest share of the research antibodies market. Its ability to quantify as little as 0.1 nanograms of protein in a sample with high specificity makes it an indispensable tool in proteomic research; this is the key factor driving market growth.

On the basis of product, the reagents segment accounted for the largest share of the global research antibodies market (including reagents), in 2016. This can be attributed to the fact that a large number of reagents are used in various routine assays and techniques.

Based on application, the proteomics segment accounted for the largest share of the research antibodies market. The large share of this segment is attributed to the deployment of proteomic-based approaches in biomarker detection and cancer profiling, increasing R&D expenditure, and availability of funds from various organizations.

Based on end user, the pharmaceutical & biotechnological companies segment accounted for the largest share of the research antibodies market owing to the high uptake of research-specific antibodies in the drug discovery and development process, along with the increasing use of these research tools in the ever-developing proteomics research sector.

North America accounted for the largest share of the research antibodies market in 2016, followed by Europe. 

Read More: - https://www.marketsandmarkets.com/PressReleases/research-antibodies-reagents.asp

The major players in the research antibodies market (including reagents) are Thermo Fisher Scientific, Inc. (U.S.), Merck Group , Abcam plc (U.K.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Danaher Corporation (U.S.), GenScript (U.S.), PerkinElmer, Inc. (U.S.), Lonza (Switzerland), and BioLegend, Inc. (U.S.).

Urinary Catheters Market: Emerging Trends and Global Future Forecast

The growth in this market is mainly driven by the growing prevalence of urinary incontinence, increasing number of surgical procedures across the globe, and the favorable reimbursement scenario. The growing preference for single-use catheters and self-catheterization is a major trend that is expected to boost market growth in the coming years.

The Urinary Catheters Market is expected to reach USD 2.19 Billion by 2022 from USD 1.45 Billion in 2017, at a CAGR of 8.5% during the forecast period. 

Download PDF Brochure:- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629

Based on product, the urinary catheters market is segmented into Foley catheters, intermittent catheters, and condom catheters. In 2017, the Foley catheters segment is expected to dominate this market, primarily due to the rising geriatric population and increasing incidence of urinary incontinence.

On the basis of type, the urinary catheters market is segmented into coated urinary catheters and uncoated urinary catheters. In 2017, coated urinary catheters are expected to dominate the market. Coated catheters ensure easier, more comfortable insertion, thereby reducing the risk of urethral damage and leading to better patient satisfaction. These advantages are driving the adoption of coated catheters.

On the basis of the region, the urinary catheters market is segmented into North America, Europe, Asia, and RoW. In 2017, North America accounted for the largest share of the market, followed by Europe.

Read More:- 

https://www.marketsandmarkets.com/PressReleases/urinary-catheter.asp

The urinary catheters market is highly competitive with the presence of major players. B. Braun Melsungen AG (Germany), Coloplast A/S (Denmark), C.R. Bard, Inc. (US), Hollister Incorporated (US), Medtronic plc (Ireland), Cook Medical (US), Teleflex Incorporation (US), and ConvaTec Group plc (UK) are the major companies operating in the urinary catheters market.

Report explores the Nucleic Acid Isolation and Purification Market

The growth of this market can mainly be attributed to the increasing R&D activities as well as technological advancements and increasing automation. On the other hand, the high cost of automated instruments is expected to hinder the growth of the market.

The global Nucleic Acid Isolation and Purification Market is projected to reach USD 4.8 billion by 2025 from USD 3.2 billion in 2020, at a CAGR of 8.9% during the forecast period. 

Download PDF Brochure:- 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229978287

On the basis of product, the nucleic acid isolation and purification market has been segmented into kits, reagents, and instruments. The kits segment accounted for the largest share of the global nucleic acid isolation and purification market in 2019. Growth in this market can be attributed to the low cost and easy usage of kits in applications such as gene sequencing, molecular diagnostics, and gene cloning.

On the basis of application, the global nucleic acid isolation and purification market is segmented into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and other applications. In 2019, the diagnostics segment accounted for the largest share of the global nucleic acid isolation and purification market; this segment is also expected to register the highest CAGR during the forecast period.

On the basis of type, the global nucleic acid isolation and purification market is segmented into plasmid DNA isolation and purification, total RNA isolation and purification, circulating nucleic acid isolation and purification, genomic DNA isolation and purification, messenger RNA isolation and purification, microRNA isolation and purification, PCR cleanup, and other nucleic acid isolation and purification types. In 2019, the plasmid DNA isolation segment accounted for the largest share of the market. 

In 2019, North America accounted for the largest share of the nucleic acid isolation and purification market, followed by Europe.

Read More:- 

https://www.marketsandmarkets.com/PressReleases/nucleic-acid-isolation-purification.asp

QIAGEN N.V. (Netherlands), Thermo Fisher Scientific (US), and F. Hoffmann-La Roche Ltd. (Switzerland) are the key players operating in the nucleic acid isolation and purification market. 

Particle Size Analysis Market - Global Forecast to 2025

Increasing research activities in the field of nanotechnology, rising investments in pharmaceutical R&D, and stringent regulatory guidelines for product quality across industries are fueling the growth of the market. Moreover, increasing government support for nanotechnology research and the rapidly growing pharmaceutical industry in emerging countries are some of the other major factors driving the growth of this market.

The report Particle Size Analysis Market  is projected to reach USD 465 million by 2025 from USD 356 million in 2020, growing at a CAGR of 5.5% during the forecast period.

Download PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=74084833

Based on technology, the market is segmented into laser diffraction, dynamic light scattering, imaging, coulter principle, nanoparticle tracking analysis, and other technologies. The laser diffraction segment accounted for the largest share of the particle size analysis market in 2019, driven by the growing initiatives to create awareness about laser diffraction, increasing R&D expenditure in the pharma and biotech sectors, and rising food safety concerns.

Based on type, the imaging market is segmented into two major types—dynamic imaging and static imaging. Factors such as high-quality/resolution images, better image recognition, user-friendliness, individual sample measurement, and high-speed analysis are driving the growth of the dynamic imaging segment.

The Nanoparticle Tracking Analysis (NTA) segment is expected to register the highest growth during the forecast period by technology. The significant growth of this segment is attributed to advanced applications of these particle size analyzers and growing research activities in the field of nanotechnology.

The particle size analysis industry is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American region accounted for the largest share of the particle size analysis market in 2019.

Read More: - https://www.marketsandmarkets.com/PressReleases/particle-size-analysis.asp

The major players operating in the particle size analysis market are Malvern Panalytical (UK), HORIBA (Japan), Beckman Coulter, (UK), MICROTRAC MRB, (US), Izon Science (UK), Micromeritics Instrument Corporation (US), Shimadzu Corporation (Japan), Sympatec (Germany), Anton Paar (Austria), TSI (US), Bettersize Instruments (China), FRITSCH (Germany), Brookhaven Instruments, (US), LS Instruments AG (Switzerland), and AimSizer (China).

APAC to be a Key Revenue Pocket for Revenue Cycle Management Market

Revenue Cycle Management (RCM) in healthcare industry has fast become a buzzword over the past few years. It enables the healthcare organizations to manage payments, claims processing, and revenue generation, thereby accelerating the whole revenue cycle in an efficient manner. RCM solution begins when a patient enters or schedules an appointment. It automates the whole procedure with initiation of the process by the patient, quick follow ups, determining the eligibility of the patient, collecting their payment, effective tracking of the claims process, and working on rejected claims among others. The rising need for streamlining the whole process has further boosted the demand for RCM solutions, thereby triggering the growth of the RCM market.

The global Revenue cycle management market is expected to reach USD 90.43 Billion by 2022 from USD 51.07 Billion in 2017, at a CAGR of 12.1%. Regulatory mandates for the adoption of EHR/EMR and government initiatives to boost the adoption of RCM solutions are the major factors driving the adoption of RCM solutions.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153900104

  

On the basis of function, the market is broadly segmented into claim and denial management, medical billing and coding, patient insurance eligibility check, payment remittance, electronic health record (EHR), clinical documentation improvement (CDI), and others. The claim and denial management segment is expected to account for the largest share of the global revenue cycle management market in 2017 and is expected to witness the highest CAGR during the forecast period. The growing demand for claims and denial management due to the dynamic reimbursement structure and the increasing instances of claim denials are the major factors driving the growth of this segment.

What’s driving the Market?

The growth of the global revenue cycle management market is primarily propelled by the following factors:

Ø  Declining reimbursement scenarios

Ø  Increased initiatives and support from the government

Ø  Reduced healthcare costs

Ø  Consolidation of healthcare providers

Although this market is set to witness a healthy growth ahead, higher costs of RCM solutions and limited number of investments being made in healthcare IT sector are likely to inhibit the growth of this market over the forecast period.

Request for Sample Report:-https://www.marketsandmarkets.com/requestsample.asp?id=153900104 

The key players in the global revenue cycle management market are McKesson (US), Cerner (US), Quest Diagnostics (US), Allscripts Health Solutions (US), and athenahealth (US).

Membrane Chromatography Market to Witness Steady Growth in the Near Future

The increasing demand for biopharmaceuticals, increasing R&D expenditure in the biopharmaceutical industry, significant benefits of membrane chromatography over conventional chromatography methods, and increasing regulatory scrutiny on the cleaning validation of downstream purification processes are some the factors driving the growth of this market.

The global Membrane Chromatography Market is expected to reach USD 290.6 Million by 2022 from USD 126.6 Million in 2017, at a CAGR of 18.1%.

Download PDF Brochure: - https://www.marketsandmarkets.com/Market-Reports/membrane-chromatography-market-151487196.html             

On the basis of product, the market is broadly segmented into consumables and accessories. The consumables segment is expected to account for the largest share of the global membrane chromatography market in 2017 and is projected to register the highest CAGR during the forecast period.

On the basis of technique, the market is broadly segmented into ion exchange membrane chromatography, affinity membrane chromatography, and hydrophobic interaction membrane chromatography. The ion exchange membrane chromatography segment is expected to account for the largest share of the global membrane chromatography market in 2017.

On the basis operation mode, the market is broadly segmented into flow-through membrane chromatography and bind-elute membrane chromatography. The flow-through membrane chromatography segment is expected to account for the largest share of the global membrane chromatography market in 2017 and bind elute membrane chromatography is expected to witness the highest CAGR during the forecast period. 

Read More:- 

https://www.marketsandmarkets.com/PressReleases/membrane-chromatography.asp

In 2017, North America is expected to account for the largest share of the global membrane chromatography market. 

The key players in the global membrane chromatography market are Sartorius (Germany), GE Healthcare (US), Danaher (US), Merck Millipore (US), and 3M Company (US).